PE Reperfusion / IR Consult Triage

    Educational tool to support monitoring vs escalation decisions and when to involve Pulmonary/PERT and IR.

    Not medical advice. Use local PE/PERT protocols and clinical judgment. Do not enter patient identifiers or free-text case details. This tool does not store or transmit data.

    1 Context
    2 Hemodynamics
    3 RV
    4 Biomarkers
    5 Trajectory
    6 Modifiers

    1 Context

    Stability window used by this tool: last 4–6 hours (ED).

    Step 1 of 6

    2 Hemodynamics / Instability Screen

    Step 2 of 6

    3 RV Dysfunction

    Step 3 of 6

    4 Biomarkers

    Step 4 of 6

    5 Trajectory / Objective Deterioration

    Objective deterioration within the stability window (ED: 4–6h).

    Do not use this if escalation occurred due to bed availability.

    Step 5 of 6

    6 Timing / Anatomy / Safety Modifiers

    Step 6 of 6
    • STORM-PE (RCT, 2024): In intermediate-high risk PE, computer-assisted vacuum thrombectomy + anticoagulation improved 48-hour RV/LV reduction vs anticoagulation alone and normalized vital signs earlier; no demonstrated mortality benefit; procedure risks exist.
    • PEERLESS (RCT, 2024): In patients selected for catheter intervention, large-bore mechanical thrombectomy outperformed catheter-directed thrombolysis on a composite driven by less deterioration/bailout and less ICU utilization/shorter LOS; no difference in mortality or major bleeding.
    • Guideline framing (ESC/ACC summaries): Systemic thrombolysis is reserved for high-risk hemodynamic instability; routine reperfusion is not recommended for stable intermediate-risk PE; catheter-based or surgical options are generally considered for rescue when instability develops or when thrombolysis is contraindicated/failed.
    • Access-site bleeding/hematoma; vascular injury
    • Pulmonary artery injury/rupture (rare, serious)
    • Cardiac irritation/arrhythmias; heart block (device-dependent)
    • Hemolysis and possible renal stress (device-dependent)
    • Limited reach for distal clot; residual segmental disease may persist
    • Potential embolization/clot migration

    Recommendation

    Complete the form to see recommendation.

    Need a clinical tool built for your workflow?

    We build fast, clinician-centered calculators and decision support tools. If you want this pathway adapted to your hospital's PE/PERT protocol—or want a calculator for another condition—let's talk.

    Written and reviewed by Pouyan Golshani, MD, Interventional Radiologist — Last updated April 7, 2026